Evidence map›Paper›PMID 42525261›Full record

ArticleVirchows Archiv : an international journal of pathology2026

Chondromyxoid fibroma with limited or no chondromyxoid stroma: A clinicopathological study of 3 cases.

Ken-Ichi Yoshida, Toru Motoi, Toru Wakamatsu, Satoshi Takenaka, Toshihide Hirai, Koichiro Mori, Eisuke Kobayashi, Akihiko Yoshida

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ken-Ichi YoshidaDepartment of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
Toru MotoiDepartment of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Toru WakamatsuDepartment of Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
Satoshi TakenakaDepartment of Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
Toshihide HiraiDepartment of Orthopedic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Koichiro MoriDepartment of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Eisuke KobayashiDepartment of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
Akihiko YoshidaDepartment of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. akyoshid@ncc.go.jp.ORCID http://orcid.org/0000-0002-3373-0099

Funding

Japan Society for the Promotion of Science JP21K06919
6 · The paper itself

Abstract

Chondromyxoid fibroma (CMF) is a rare benign bone tumor characterized by lobulated growth, chondromyxoid stroma, and GRM1 rearrangement. Here, we describe 3 cases of CMF with limited or no chondromyxoid stroma. The patients (2 males and 1 female) were 14-18 years old and had lesions in the tibial diaphysis, rib, and pubic bone. The tumors measured 24-60 mm, and were central in 2 cases and juxtacortical in 1 case. Treatment included curettage and resection, and the tumors did not recur for 2 to 8 years after surgery. Histologically, all 3 tumors comprised sheets of uniform, non-atypical, ovoid or short spindle cells interspersed with numerous osteoclast-like giant cells. Delicate pericellular eosinophilic matrix was focally deposited in all cases, which showed chicken-wire calcification in 2 cases. Osteoid deposition in a conglomerate pattern was observed in 2 cases. Aneurysmal bone cystic changes were present in all cases. Chondromyxoid stroma was present only in ~ 10% and < 5% of the tumor volume in 2 cases, whereas it was absent in the remaining case. All 3 cases showed diffuse immunohistochemical expression of GRM1, and GRM1 rearrangement was confirmed with fluorescence in situ hybridization. CMF with limited or no chondromyxoid stroma is a rare variant that histologically overlaps with other giant cell-rich tumors. Recognition of this pattern is essential for appropriate clinical management, and the demonstration of GRM1 rearrangement and overexpression provides strong support for this challenging diagnosis.

Indexed as

BoneChondromyxoid fibromaGiant cellGRM1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.